The MYCN Oncogene as a Specific and Selective Drug Target for Peripheral and Central Nervous System Tumors

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|5|4|273-283

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.5, Iss.4, 2005-06, pp. : 273-283

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechlorethamine based Drug Structures for Intervention of Central Nervous System Tumors

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 13, Iss. 2, 2013-06 ,pp. : 114-121

Bentham Science Publishers

Access to resources Recommend Favorite

Drug-Resistance in Central Nervous System Tumors: From the Traditional Cell-Resistance Model to the Genetically Driven Approaches on Therapy

By  

Current Pharmaceutical Biotechnology, Vol. 8, Iss. 2, 2007-04 ,pp. : 105-113

Bentham Science Publishers

Access to resources Recommend Favorite

Structure and Functions of Lectins in the Central and Peripheral Nervous System

By  

Cells Tissues Organs, Vol. 161, Iss. 1-4, 1998-10 ,pp. : 180-195

Karger

Access to resources Recommend Favorite

Histamine H3 Receptor: A Potential Drug Target for the Treatment of Central Nervous System Disorders

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 5, 2003-01 ,pp. : 303-313

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-HIV Drug Distribution to the Central Nervous System

By  

Current Pharmaceutical Design, Vol. 10, Iss. 12, 2004-05 ,pp. : 1313-1324

Bentham Science Publishers

Access to resources Recommend Favorite